pharma · Metachromatic Leukodystrophy (MLD) · Late Metachromatic Leukodystrophy (MLD)
Shire
Shire is a pharma organization headquartered in CN. Primary therapeutic focus areas include Metachromatic Leukodystrophy (MLD), Late Metachromatic Leukodystrophy (MLD), Hunter Syndrome, Cytomegalovirus (CMV), Crohn's Dis
JP HQ
3,523 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- JP
- Employees
- 3,523
- Programs
- 9
- Drugs
- 8
- Patents
- 0
Maribavir
Phase 3 · small molecule · Cytomegalovirus (CMV)
Maribavir for Cytomegalovirus (CMV) is a Phase 3 program (small_molecule) at Shire with 2 ClinicalTrials.gov record(s).
Internal code SHP620-302
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shire
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Cytomegalovirus (CMV)
- Status
- completed
- Trials
- 2